Company registration number 06019901 (England and Wales)
MEDLOCK & SONS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
MEDLOCK & SONS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
MEDLOCK & SONS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Investments
4
1
1
Current assets
Debtors
5
123,099
150,375
Cash at bank and in hand
15,976
4,741
139,075
155,116
Creditors: amounts falling due within one year
6
(12,783)
(20,340)
Net current assets
126,292
134,776
Total assets less current liabilities
126,293
134,777
Creditors: amounts falling due after more than one year
7
(21,160)
(56,499)
Net assets
105,133
78,278
Capital and reserves
Called up share capital
8
150
150
Profit and loss reserves
104,983
78,128
Total equity
105,133
78,278

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 12 August 2026
Mr A G Medlock
Director
Company registration number 06019901 (England and Wales)
MEDLOCK & SONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Medlock & Sons Limited is a private company limited by shares incorporated in England and Wales. The registered office is 39/43 Bridge Street, Swinton, Mexborough, South Yorkshire, England, S64 8AP.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue comprises sales of goods or services provided to customers net of other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments
MEDLOCK & SONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

MEDLOCK & SONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
1
1
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
123,099
150,375

6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
5,340
5,342
Trade creditors
-
0
232
Taxation and social security
6,417
2,995
Other creditors
1,026
11,771
12,783
20,340
MEDLOCK & SONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
6
Creditors: amounts falling due within one year
(Continued)
- 5 -

7
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
21,160
26,499
Other borrowings
-
0
30,000
21,160
56,499

8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary 'A' Shares of £1 each
100
100
100
100
Ordinary 'B' Shares of £1 each
20
20
20
20
Ordinary 'C' Shares of £1 each
10
10
10
10
Ordinary 'D' Shares of £1 each
10
10
10
10
Ordinary 'E' Shares of £1 each
10
10
10
10
150
150
150
150
2025-12-31 2025-01-01 false false false 12 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr A G Medlock 06019901 2025-01-01 2025-12-31 06019901 2025-12-31 06019901 2024-12-31 06019901 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 06019901 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 06019901 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 06019901 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 06019901 core:CurrentFinancialInstruments 2025-12-31 06019901 core:CurrentFinancialInstruments 2024-12-31 06019901 core:Non-currentFinancialInstruments 2025-12-31 06019901 core:Non-currentFinancialInstruments 2024-12-31 06019901 core:ShareCapital 2025-12-31 06019901 core:ShareCapital 2024-12-31 06019901 core:RetainedEarningsAccumulatedLosses 2025-12-31 06019901 core:RetainedEarningsAccumulatedLosses 2024-12-31 06019901 core:ShareCapitalOrdinaryShareClass1 2025-12-31 06019901 core:ShareCapitalOrdinaryShareClass1 2024-12-31 06019901 core:ShareCapitalOrdinaryShareClass2 2025-12-31 06019901 core:ShareCapitalOrdinaryShareClass2 2024-12-31 06019901 core:ShareCapitalOrdinaryShareClass3 2025-12-31 06019901 core:ShareCapitalOrdinaryShareClass3 2024-12-31 06019901 core:ShareCapitalOrdinaryShareClass4 2025-12-31 06019901 core:ShareCapitalOrdinaryShareClass4 2024-12-31 06019901 core:ShareCapitalOrdinaryShareClass5 2025-12-31 06019901 core:ShareCapitalOrdinaryShareClass5 2024-12-31 06019901 core:ShareCapitalOrdinaryShares 2025-12-31 06019901 core:ShareCapitalOrdinaryShares 2024-12-31 06019901 bus:Director1 2025-01-01 2025-12-31 06019901 2024-01-01 2024-12-31 06019901 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 06019901 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 06019901 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 06019901 bus:OrdinaryShareClass4 2025-01-01 2025-12-31 06019901 bus:OrdinaryShareClass5 2025-01-01 2025-12-31 06019901 bus:OrdinaryShareClass1 2025-12-31 06019901 bus:OrdinaryShareClass1 2024-12-31 06019901 bus:OrdinaryShareClass2 2025-12-31 06019901 bus:OrdinaryShareClass2 2024-12-31 06019901 bus:OrdinaryShareClass3 2025-12-31 06019901 bus:OrdinaryShareClass3 2024-12-31 06019901 bus:OrdinaryShareClass4 2025-12-31 06019901 bus:OrdinaryShareClass4 2024-12-31 06019901 bus:OrdinaryShareClass5 2025-12-31 06019901 bus:OrdinaryShareClass5 2024-12-31 06019901 bus:AllOrdinaryShares 2025-12-31 06019901 bus:AllOrdinaryShares 2024-12-31 06019901 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 06019901 bus:FRS102 2025-01-01 2025-12-31 06019901 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 06019901 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 06019901 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP